Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-13

Clinical Trial Update: Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring the anti-cancer stem cell activity of pre-operative bevacizumab with chemotherapy in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED